PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.36%
Positive revenue growth while QCOM is negative. John Neff might see a notable competitive edge here.
15.92%
Positive gross profit growth while QCOM is negative. John Neff would see a clear operational edge over the competitor.
75.90%
Positive EBIT growth while QCOM is negative. John Neff might see a substantial edge in operational management.
75.90%
Positive operating income growth while QCOM is negative. John Neff might view this as a competitive edge in operations.
14.77%
Net income growth under 50% of QCOM's 52.02%. Michael Burry would suspect the firm is falling well behind a key competitor.
-15.38%
Negative EPS growth while QCOM is at 50.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-16.00%
Negative diluted EPS growth while QCOM is at 50.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
50.74%
Share change of 50.74% while QCOM is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
51.98%
Slight or no buyback while QCOM is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-35.45%
Dividend reduction while QCOM stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
109.22%
OCF growth above 1.5x QCOM's 52.84%. David Dodd would confirm a clear edge in underlying cash generation.
186.64%
FCF growth above 1.5x QCOM's 63.62%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-48.19%
Negative 10Y revenue/share CAGR while QCOM stands at 565.36%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
21.71%
Positive 5Y CAGR while QCOM is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-38.73%
Negative 3Y CAGR while QCOM stands at 34.91%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
36.94%
10Y OCF/share CAGR under 50% of QCOM's 5255.45%. Michael Burry would worry about a persistent underperformance in cash creation.
120.38%
5Y OCF/share CAGR at 75-90% of QCOM's 139.44%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
8.97%
3Y OCF/share CAGR under 50% of QCOM's 110.27%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
71.28%
Below 50% of QCOM's 1440.14%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
137.70%
Below 50% of QCOM's 421.53%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-45.79%
Negative 3Y CAGR while QCOM is 98.22%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
127.57%
Below 50% of QCOM's 1138.58%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
59.18%
Below 50% of QCOM's 466.87%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-36.96%
Negative 3Y equity/share growth while QCOM is at 29.94%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-5.96%
Cut dividends over 10 years while QCOM stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-4.47%
Negative 5Y dividend/share CAGR while QCOM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-34.92%
Negative near-term dividend growth while QCOM invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-4.66%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.11%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
2.81%
Asset growth at 50-75% of QCOM's 4.16%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
-31.13%
We have a declining book value while QCOM shows 5.45%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.48%
We’re deleveraging while QCOM stands at 9.92%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-4.27%
Our R&D shrinks while QCOM invests at 5.61%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.60%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.